Mather Group LLC. Purchases 2,245 Shares of Colgate-Palmolive (NYSE:CL)

Mather Group LLC. boosted its holdings in Colgate-Palmolive (NYSE:CL) by 33.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,968 shares of the company’s stock after purchasing an additional 2,245 shares during the quarter. Mather Group LLC.’s holdings in Colgate-Palmolive were worth $808,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in Colgate-Palmolive by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after buying an additional 416,853 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares during the last quarter. Norges Bank bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd lifted its stake in Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after purchasing an additional 278,150 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Colgate-Palmolive by 1.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock valued at $352,824,000 after purchasing an additional 77,679 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CL. Argus boosted their target price on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a research note on Wednesday, May 15th. TD Cowen lifted their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Finally, Citigroup boosted their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $101.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

CL traded up $1.17 on Wednesday, hitting $103.83. 1,140,149 shares of the company’s stock traded hands, compared to its average volume of 4,426,322. Colgate-Palmolive has a one year low of $67.62 and a one year high of $104.15. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90. The company’s 50 day simple moving average is $96.85 and its 200-day simple moving average is $91.20. The firm has a market cap of $85.19 billion, a price-to-earnings ratio of 32.48, a P/E/G ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the previous year, the company posted $0.77 EPS. The company’s revenue was up 4.9% compared to the same quarter last year. As a group, research analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.93%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.